Page 79 - product-manual
P. 79

TM/MC  TM/MC
             PHARMACOLOGICAL ACTIVITIES - TOXICOLOGY - DRUG INTERACTIONS





                               Artemisia capillaris (Capillary Artemisia)

                               Herba  Artemisiae  Capillaris  is  an  effective  remedy  for  liver  problems,  being  specifically
                               helpful in treating liver diseases such as hepatitis, fatty liver, cirrhosis of the liver and jaundice.
                               In dogs with chronic gallbladder fistulae, oral administration (0.3 g/kg/day) of scoparone, an
                               active constituent of Herba Artemisiae Capillaris, increased the production of bile by a mean of
                               73.86% in 3 h (Chen & Chen, 2004; Zhu, 1998). The active constituents scoparone, artepillin A,
                               capillartemisin B, and artepillin have exhibited choleretic activity in vivo (Okuno et al., 1998). In
                               studies in obese animals, Herba Artemisiae Capillaris was found to be effective in strengthening
                               the antioxidant defence system, reducing the generation of reactive oxygen species and damaging
                               oxidative substances in the liver (Hong & Lee, 2009). Herba Artemisiae Capillaris and Rhizoma
                               Picrorhizae mixtures have shown good synergic hepatoprotective activity that was attributed to
                               increasing free-radical scavenging ability (Lee et al., 2008).  Herba Artemisiae Capillaris extract
                               demonstrates anti-inflammatory activity by inhibiting the expression of inflammatory proteins
                               such as inducible nitric oxide synthase   (iNOS), cyclooxygenase-2 (COX-2) and tumor necrosis
                               factor-alpha [TNF-alpha] (Hong et al., 2004).



                Toxicity for Herba Artemisiae Capillaris has not been documented in dogs and cats when administered orally in
                therapeutic doses. The acute LD  of capillin, an active constituent of Herba Artemisiae Capillaris in mice was
                                            50
                6.98 mg/kg of body weight. In rats receiving oral administration of 50,200 and 400 mg/kg of body weight of
            TOXICOLOGY  changes were found in the blood and organ functions. The intraperitoneal LD  values of p-hydroxyacetophenone
                p-hydroxyacetophenone,  an  active  constituent  of  Herba  Artemisiae  Capillaris,  for  3  months,  no  significant
                                                                                 50
                were 0.5 g/kg of body weight in mice and 2.2 g/kg of body weight in rats (Chen & Chen, 2004). The LD  for
                                                                                                          50
                capillarin in mice is 262.5 mg/kg of body weight  via intraperitoneal injection (Zhu, 1988).

                Equivalent toxic dose in 20 kg dog:   5,310 mg IP of capillarin.
                Equivalent toxic dose in 5 kg cat:    1,313 mg IP of capillarin.



                         DRUG      Validated interactions studies do not exist for Herba Artemisiae Capillaris preparations.
                INTERACTIONS       Clinical interactions with other drugs have not been reported.

























        4  |   Hepato -VM TM
   74   75   76   77   78   79   80   81   82   83   84